Zobrazeno 1 - 10
of 105
pro vyhledávání: '"Arina J ten Cate-Hoek"'
Autor:
Rachel H P Schreurs, Manuela A Joore, Daisy P De Bruijn-Geraets, Hugo Ten Cate, Arina J Ten Cate-Hoek
Publikováno v:
PLoS ONE, Vol 17, Iss 8, p e0272566 (2022)
BackgroundAlthough compression therapy is well established for patients with deep venous thrombosis (DVT) and chronic venous disease (CVD), considerable variation exists in its organization in clinical practice which may impact patient outcomes. The
Externí odkaz:
https://doaj.org/article/6ff280ca1cad4e129983637aec992c8b
Publikováno v:
BMJ Open, Vol 11, Iss 10 (2021)
Externí odkaz:
https://doaj.org/article/1daa69e754a3426ba29e8907d0403021
Autor:
Jasper H A van Miert, Nic J G M Veeger, Arina J Ten Cate-Hoek, Margriet Piersma-Wichers, Karina Meijer
Publikováno v:
PLoS ONE, Vol 15, Iss 7, p e0235639 (2020)
BackgroundTreatment with vitamin K antagonists (VKA) requires a high proportion of time in the therapeutic range (TTR) and a low international normalised ratio (INR) variability to be maximally safe and effective. Switching from short-acting acenocou
Externí odkaz:
https://doaj.org/article/3661981a837c46298aef6dc2fc08c7a9
Autor:
Anouk J W Gulpen, Hugo Ten Cate, Yvonne M C Henskens, René van Oerle, Rick Wetzels, Simon Schalla, Harry J Crijns, Arina J Ten Cate-Hoek
Publikováno v:
PLoS ONE, Vol 14, Iss 6, p e0217302 (2019)
BackgroundDirect oral anticoagulants (DOACs) are administered in fixed doses without monitoring. There is still little published data on the impact of the absence of monitoring on adherence to medication and stability of DOAC plasma levels over time.
Externí odkaz:
https://doaj.org/article/891bf3c1a5e54cb987fd08eb0af03895
Autor:
Paola E J van der Meijden, Annemieke C Bouman, Marion A H Feijge, René van Oerle, Henri M H Spronk, Karly Hamulyák, Arina J ten Cate-Hoek, Hugo ten Cate, Johan W M Heemskerk
Publikováno v:
PLoS ONE, Vol 8, Iss 5, p e64112 (2013)
BACKGROUND: Recurrent bleeding can complicate the treatment of thrombosis patients with vitamin K antagonists (VKA), even at a well-regulated level of anticoagulation. In this proof-of-principle study, we investigated whether alterations in platelet
Externí odkaz:
https://doaj.org/article/c4bd4aca613344cf851e4bc274ad31f5
Publikováno v:
PharmacoEconomics-open, 7, 479-491. Adis International Ltd
Background and Objective: Compression therapy following deep venous thrombosis in the Netherlands is suboptimal. We assessed the budget impact of targeted care improvements. Methods: We calculated the per-patient and population healthcare resource us
Autor:
Aaron F.J. Iding, Alejandro Pallares Robles, Vincent ten Cate, Hugo ten Cate, Philipp S. Wild, Arina J. ten Cate-Hoek
Publikováno v:
Journal of Thrombosis and Haemostasis, 21(5), 1238-1247. Wiley
BACKGROUND: Deep vein thrombosis (DVT) is a multifactorial disease with several outcomes, but current classifications solely stratify based on recurrence risk.OBJECTIVES: We aimed to identify DVT phenotypes and assess their relation to recurrent veno
Autor:
Pascale Notten, André A. E. A. de Smet, Lidwine W. Tick, Marlène H. W. van de Poel, Otmar R. M. Wikkeling, Louis‐Jean Vleming, Ad Koster, Kon‐Siong G. Jie, Esther M. G. Jacobs, Harm P. Ebben, Michiel Coppens, Hugo ten Cate, Cees H. A. Wittens, Arina J. ten Cate‐Hoek
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 11 (2021)
Background The CAVA (Ultrasound‐Accelerated Catheter‐Directed Thrombolysis Versus Anticoagulation for the Prevention of Post‐Thrombotic Syndrome) trial did not show a reduction of post‐thrombotic syndrome (PTS) after additional ultrasound‐a
Externí odkaz:
https://doaj.org/article/95ab6ab7dba94b3d952531983246755f
Autor:
Aaron F. J. Iding, Bram M. M. Kremers, Alejandro Pallares Robles, Hugo ten Cate, Arina J. ten Cate-Hoek
Publikováno v:
Thrombosis and Haemostasis. Georg Thieme Verlag
Background Residual venous obstruction (RVO) is considered a risk factor of recurrence and possibly other clinical outcomes following deep vein thrombosis (DVT). Current guidelines do not support an RVO-tailored duration of anticoagulant therapy; con
Autor:
Asim Cengiz Akbulut, Ryanne A. Arisz, Constance C. F. M. J. Baaten, Gaukhar Baidildinova, Aarazo Barakzie, Rupert Bauersachs, Jur ten Berg, Wout W. A. van den Broek, H. C. de Boer, Amandine Bonifay, Vanessa Bröker, Richard J. Buka, Hugo ten Cate, Arina J. ten Cate-Hoek, S. Cointe, Ciro De Luca, Ilaria De Simone, Rocio Vacik Diaz, Françoise Dignat-George, Kathleen Freson, Giulia Gazzaniga, Eric C. M. van Gorp, Anxhela Habibi, Yvonne M. C. Henskens, Aaron F. J. Iding, Abdullah Khan, Gijsje H. Koenderink, Akhil Konkoth, Romaric Lacroix, Trisha Lahiri, Wilbur Lam, Rachel E. Lamerton, Roberto Lorusso, Qi Luo, Coen Maas, Owen J. T. McCarty, Paola E. J. van der Meijden, Joost C. M. Meijers, Adarsh K. Mohapatra, Neta Nevo, Alejandro Pallares Robles, Philippe Poncelet, Christoph Reinhardt, Wolfram Ruf, Ronald Saraswat, Claudia Schönichen, Roger Schutgens, Paolo Simioni, Stefano Spada, Henri M. H. Spronk, Karlygash Tazhibayeva, Jecko Thachil, L. Vallier, Alicia Veninga, Peter Verhamme, Chantal Visser, Steve P. Watson, Philip Wenzel, Ruth A. L. Willems, Anne Willers, Pengyu Zhang, Konstantinos Zifkos, Anton Jan van Zonneveld
Publikováno v:
Thrombosis and Haemostasis. Georg Thieme Verlag
Thrombosis and haemostasis. Schattauer GmbH
Thrombosis and haemostasis. Schattauer GmbH
The Fourth Maastricht Consensus Conference on Thrombosis included the following themes. Theme 1: The “coagulome” as a critical driver of cardiovascular disease. Blood coagulation proteins also play divergent roles in biology and pathophysiology,